DE60115414D1 - N-heterosubstituierten salicylaten zur behandlung von krebs - Google Patents

N-heterosubstituierten salicylaten zur behandlung von krebs

Info

Publication number
DE60115414D1
DE60115414D1 DE60115414T DE60115414T DE60115414D1 DE 60115414 D1 DE60115414 D1 DE 60115414D1 DE 60115414 T DE60115414 T DE 60115414T DE 60115414 T DE60115414 T DE 60115414T DE 60115414 D1 DE60115414 D1 DE 60115414D1
Authority
DE
Germany
Prior art keywords
cancer
treatment
salicylates
cystine
heterosubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115414T
Other languages
English (en)
Inventor
Wilhelm Gout
Nicholas Bruchovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002307278A external-priority patent/CA2307278A1/en
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of DE60115414D1 publication Critical patent/DE60115414D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DE60115414T 2000-04-28 2001-04-27 N-heterosubstituierten salicylaten zur behandlung von krebs Expired - Lifetime DE60115414D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20035800P 2000-04-28 2000-04-28
CA002307278A CA2307278A1 (en) 2000-04-28 2000-04-28 Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine
PCT/CA2001/000570 WO2001082907A2 (en) 2000-04-28 2001-04-27 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine

Publications (1)

Publication Number Publication Date
DE60115414D1 true DE60115414D1 (de) 2006-01-05

Family

ID=25681769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115414T Expired - Lifetime DE60115414D1 (de) 2000-04-28 2001-04-27 N-heterosubstituierten salicylaten zur behandlung von krebs

Country Status (5)

Country Link
EP (1) EP1278521B1 (de)
AT (1) ATE311189T1 (de)
AU (1) AU2001254559A1 (de)
DE (1) DE60115414D1 (de)
WO (1) WO2001082907A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910560A (en) * 1996-11-29 1999-06-08 Sumitomo Chemical Company, Ltd. Thermoplastic resin composition and molded article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
CS142691A3 (en) * 1991-05-15 1992-11-18 Vyzk Ustav Farm Biochem Sp Process for preparing 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/-acetylsalicylic acid
SE9103397D0 (sv) * 1991-11-18 1991-11-18 Kabi Pharmacia Ab Nya substituerade salicylsyror

Also Published As

Publication number Publication date
EP1278521A2 (de) 2003-01-29
WO2001082907A3 (en) 2002-08-08
WO2001082907A2 (en) 2001-11-08
EP1278521B1 (de) 2005-11-30
AU2001254559A1 (en) 2001-11-12
ATE311189T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
BR0208338A (pt) Derivados de piridina
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE468889T1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60106954D1 (de) Resorcin-derivate
ATE538096T1 (de) Pyridinon-derivate zur behandlung von arteriosklerose
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
ATE256131T1 (de) Calanolide zur hemmung von btk
SE0102315D0 (sv) Compounds
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
DK1313462T3 (da) Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer
CY1106319T1 (el) Τοπικη θepαπεια στη μασταλγια
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
BRPI0410669A (pt) inibidores de caspase e usos dos mesmo
ES2243579T3 (es) Derivados de pirazolopirideno.
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
MY133969A (en) Indoloquinazolinones
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.

Legal Events

Date Code Title Description
8332 No legal effect for de